Global Optic Atrophy Management market size is expected to reach $12.32 billion by 2030 at 6.7%, segmented as by disulfiram, oral disulfiram, injectable disulfiram
Read More
Urea cycle disorders treatment market to reach $1.71 billion by 2030 at 4.6% CAGR, driven by rising number of chronic kidney disorder cases.
Read More
Unit dose manufacturing market to reach $106.79 billion by 2030 at 22.3% CAGR, driven by rising healthcare spending and focus on medication safety.
Read More
Global Opioid-Induced Constipation Treatment market size is expected to reach $2.54 billion by 2030 at 5.9%, segmented as by laxatives, osmotic laxatives, stimulant laxatives, bulk-forming laxatives
Read More
Ublituximab market to reach $2.24 billion by 2030 at 12.3% CAGR, driven by rising incidence of autoimmune disorders and improved diagnostic awareness.
Read More
Opioid use disorder market to reach $7.82 billion by 2030 at 12.5% cagr, driven by growing number of opioid addiction cases.
Read More
Tyrosine kinase inhibitors market to reach $95.44 billion by 2030 at 8.9% CAGR, driven by increasing prevalence of cancer and adoption of targeted therapies.
Read More
Ophthalmoplegia market size is expected to reach $2.95 Billion by 2030 at 9.8%, driven by increasing incidence of neurological disorders.
Read More
Tylosin market to reach $1 billion by 2030 at 4.9% CAGR, driven by rising meat production and modernization of livestock farming practices.
Read More
Global Ophthalmology Medical Service market size is expected to reach $65.9 by 2030 at 6%, rise in screen time driving growth of the market due to increasing pediatric eye conditions
Read More